Shows the potential of a new radiotracer for HDAC8 imaging in brain disorders, indicating its future relevance.
HDACs play important roles in various neurological disorders. Unlike other HDAC subtypes that have been extensively studied in neurodegenerative diseases, HDAC8 has only recently emerged as a regulator in the central nervous system. In this study, we designed and successfully radiosynthesized [¹¹C]HYF031 as a potential HDAC8 radioligand with acceptable radiochemical yield and purity. In vitro autoradiography and self-blocking dynamic PET/CT studies in C57BL/6 mice demonstrated specific binding of [¹¹C]HYF031 to HDAC proteins in the brain. Dynamic PET imaging further showed measurable brain uptake and pharmacokinetic properties compatible with PET imaging. Biodistribution studies indicated that the tracer is primarily metabolized through the hepatobiliary system. Overall, these results suggest that [¹¹C]HYF031 is a promising lead tracer for HDAC8 imaging.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: